Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220015036 220015110 null 94.2 Palliative (P) 2013-04-03 2013-08-29 BENDAMUSTINE + RITUXIMAB N N 220001559 VENETOCLAX
220015037 220015110 1.7 null Disease modification (D) 2016-01-31 2016-03-05 VIDE Y null 220001559 MELPHALAN
220015038 220009685 1.67 68.8 Palliative (P) 2017-09-30 2017-12-24 DABRAFENIB + TRAMETINIB N N 220002814 UKALL2011
220015039 220009686 null 53.6 Palliative (P) 2016-09-06 2016-09-07 LENALIDOMIDE N N 220003896 DAUNORUBICIN
220015040 220009688 1.83 76 null 2015-08-06 2016-06-30 LIPOSOMAL DOXORUBICIN N N 220003896 PEMBROLIZUMAB
220015041 220009693 1.81 11.4 Palliative (P) 2017-02-24 2017-03-03 BEP 3 day N N 220004682 TRASTUZUMAB
220015042 220009693 1.77 89.9 Palliative (P) 2016-10-07 2016-10-30 Capecitabine + Oxaliplatin 21day N N 220004682 CETUXIMAB
220015043 220009694 1.58 84.8 Curative (C) 2017-07-08 2018-03-12 PEMBROLIZUMAB N N 220006910 EOX
220015044 220015116 1.96 79 Curative (C) 2018-07-22 2018-07-22 IPILIMUMAB + NIVOLUMAB 1 N 220006910 CVP R
220015045 220009695 1.75 91.6 Curative (C) null 2015-07-02 RAVVA TRIAL N N 220009544 PEMETREXED
220015046 220009697 1.81 46.1 Palliative (P) 2017-12-30 2018-02-16 PEMBROLIZUMAB 01 N 220010163 CAMELLIA TRIAL
220015047 220015117 1.81 89.4 Disease modification (D) 2015-03-04 2015-03-18 Cisplatin 7 day N N 220011016 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220015048 220015118 1.65 60.6 Palliative (P) 2016-07-25 2016-07-25 CAPECITABINE + TEMOZOLOMIDE N N 220013190 CAPECITABINE + OXALIPLATIN
220015049 220009699 1.6 125 Curative (C) 2016-03-05 2016-03-06 CARBOPLATIN + RT N N 220013384 ARSENIC TRIOXIDE + ATRA
220015050 220009699 null 106.2 Curative (C) 2018-06-24 2018-06-27 MERCAPTOPURINE + METHOTREXATE 02 N 220013384 CISPLATIN + FLUOROURACIL
220015051 220015122 1.55 72.6 Curative (C) 2015-07-05 2015-08-02 Clofarabine+Cytarabine+Idarubicin N N 220014128 ETOPOSIDE
220015052 220009704 null null Curative (C) null 2016-04-11 Alemtuzumab+Busulfan+CyclophosphMUD N null 220014290 MIDAC
220015053 220009705 null 21.25 Disease modification (D) 2014-11-29 2014-12-09 Capecitabine N N 220014919 CAV
220015054 220009706 null null null 2016-08-08 2016-08-08 CHOP R - 21 days N null 220015896 LENALIDOMIDE
220015055 220009706 1.65 null null 2018-01-22 2018-01-22 BORTEZOMIB + THALIDOMIDE null null 220015896 ETOPOSIDE
220015056 220018243 1.74 78.4 Curative (C) 2017-09-30 2017-09-30 Ipilimumab N N 220016525 LIPOSOMAL CYTARABINE
220015057 220018243 1.79 52.8 Palliative (P) 2014-05-19 2014-07-05 AML LI-1 Trial N N 220016525 GEMCITABINE
220015058 220009707 1.7 43.85 Disease modification (D) 2015-04-21 2015-04-21 FLUDARABINE N N 220016746 IGEV R
220015059 220015124 1.65 84.6 Curative (C) null 2016-08-24 Lenalidomide 25mg (Cycle 1 to 25) N N 220017143 MERCAPTOPURINE + METHOTREXATE
220015060 220018244 1.61 74.2 Curative (C) 2015-09-28 2016-12-01 FCR N N 220017507 CAPECITABINE + OXALIPLATIN
220015061 220009709 1.57 113.9 Curative (C) 2013-11-19 2013-12-02 CISPLATIN + FLUOROURACIL N N 220017673 AFATINIB
220015062 220009711 null 72.3 Neo-adjuvant (N) 2015-05-18 2015-05-18 LENALIDOMIDE N N 220018110 IPILIMUMAB + NIVOLUMAB
220015063 220009712 null null null 2017-07-15 2017-07-15 LENALIDOMIDE null N 220018242 CYTARABINE + FLUDARABINE + IDARUBICIN
220015064 220009719 1.55 89.6 Curative (C) 2016-05-24 2016-05-28 CARBOPLATIN + VINORELBINE N N 220018543 CARBOPLATIN
220015065 220009720 1.65 63.9 Palliative (P) 2018-06-07 2018-06-07 CARBOPLATIN null N 220018755 ERIBULIN
220015066 220009721 1.85 61.2 Disease modification (D) 2012-07-14 2018-01-06 Cetuximab + FOLFIRI cycle1 02 N 220019679 CISPLATIN + PEMETREXED
220015067 220009722 1.76 57 null null 2017-08-11 EOX 01 N 220020424 VIDE
220015068 220009724 1.7 70.8 Curative (C) 2018-02-20 2018-02-20 Doxorubicin + Ifosfamide 02 N 220020429 MERCAPTOPURINE + METHOTREXATE
220015069 220009725 1.81 95.4 Curative (C) 2013-06-14 2013-06-14 Cladribine (subcut) 5 days 02 N 220020796 ETOPOSIDE
220015071 220015129 null 67.3 Palliative (P) 2018-10-17 2018-10-30 Ifosfamide N N 220021062 PAZOPANIB
220015072 220009728 1.58 58 Curative (C) 2014-11-28 2015-01-13 Busulfan Oral N N 220021070 GEMCITABINE
220015073 220009730 1.66 0 Palliative (P) 2013-06-12 2013-06-21 Cetuximab +Cisplatin + FU (Cycle 1) Y N 220021070 CISPLATIN + RT
220015074 220009730 1.7 71 Curative (C) 2018-01-11 2018-01-21 BUSULFAN 01 N 220021070 IPILIMUMAB
220015075 220009732 1.73 60.6 Curative (C) 2015-06-14 2015-06-20 Carboplatin + Liposomal Doxorubicin 01 N 220021593 FLA
220015076 220009732 1.58 70.5 Palliative (P) 2015-12-05 2015-12-26 DABRAFENIB + TRAMETINIB 02 N 220021593 ARSENIC TRIOXIDE + ATRA
220015077 220009732 1.62 78.4 Curative (C) 2017-08-04 2017-09-20 DOXORUBICIN 2 N 220021593 CAPECITABINE + CARBOPLATIN
220015078 220015132 1.36 null Curative (C) 2013-11-25 2014-02-18 Bevacizumab 7.5mg/kg 02 N 220021758 ALEMTUZUMAB + CYCLO + FLUDARABINE
220015079 220009736 1.69 null Curative (C) 2016-01-09 2016-01-17 DHAP 99 null 220021845 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220015080 220009737 null null Palliative (P) 2019-09-16 2019-09-16 Capecitabine + Oxaliplatin 21day N null 220021899 FLUDARABINE
220015081 220009738 1.8 75 Curative (C) 2017-05-05 2017-05-05 CLOFARABINE + DAUNORUBICIN 02 null 220021916 PEMBROLIZUMAB
220015082 220015133 1.6 71 Curative (C) 2018-11-26 2018-12-17 Ipilimumab N N 220021916 CAPECITABINE + OXALIPLATIN
220015083 220009739 1.7 65 Curative (C) null 2014-04-07 EOX 2 N 220022309 CETUXIMAB + RT
220015084 220009742 1.65 84.8 Curative (C) null 2019-03-25 Bendamustine+Rituximab(Sub Courses) null N 220022614 IPILIMUMAB
220015085 220009742 1.8 85.5 Curative (C) 2016-02-11 2016-02-16 Busulfan Oral 02 N 220022614 CYCLOPHOSPHAMIDE + FLUDARABINE + THIOTEPA
220015086 220009742 1.63 66.5 Palliative (P) 2017-12-22 2017-12-24 Liposomal Doxorubicin (Caelyx) 2 N 220022614 CLADRIBINE + CYTARABINE + DAUNORUBICIN